drugset / Trial / NCT01900340

Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans

NCT01900340 ↗

Phase 1 Completed 12 enrolled University Hospital, Basel, Switzerland
RandomizedCrossoverQuadruple-blindBasic science

Summary

The aim is to further establish a physiological role for GLP-1 as an endogenous satiety signal by examining the effect of the specific GLP-1 receptor antagonist exendin (9-39) on appetite and food intake in healthy male subjects.

Timeline

Start
2011-11
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator exendin(9-39)NH2 Unknown — —

Indications